CY1111983T1 - Φαρμακευτικη συνθεση και μεθοδος χρησης αντιμυκητιακου παραγοντα σε συνδυασμο - Google Patents
Φαρμακευτικη συνθεση και μεθοδος χρησης αντιμυκητιακου παραγοντα σε συνδυασμοInfo
- Publication number
- CY1111983T1 CY1111983T1 CY20111100835T CY111100835T CY1111983T1 CY 1111983 T1 CY1111983 T1 CY 1111983T1 CY 20111100835 T CY20111100835 T CY 20111100835T CY 111100835 T CY111100835 T CY 111100835T CY 1111983 T1 CY1111983 T1 CY 1111983T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pharmaceutical composition
- antificial
- agent
- combination
- general formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Φαρμακευτική σύνθεση περιέχουσα έναν ή περισσότερους αντιμηκυτιακούς παράγοντες που επιλέγονται από παράγωγο αρυλαμιδίνης που αντιπροσωπεύεται από το γενικό τύπο:
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005110784 | 2005-04-07 | ||
EP06731152A EP1867332B1 (en) | 2005-04-07 | 2006-04-05 | Pharmaceutical composition and method using antifungal agent in combination |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1111983T1 true CY1111983T1 (el) | 2015-11-04 |
Family
ID=37086920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20111100835T CY1111983T1 (el) | 2005-04-07 | 2011-08-30 | Φαρμακευτικη συνθεση και μεθοδος χρησης αντιμυκητιακου παραγοντα σε συνδυασμο |
Country Status (19)
Country | Link |
---|---|
US (1) | US8993603B2 (el) |
EP (1) | EP1867332B1 (el) |
JP (1) | JP5216323B2 (el) |
KR (1) | KR101325620B1 (el) |
CN (1) | CN101151032B (el) |
AU (1) | AU2006234228B2 (el) |
BR (1) | BRPI0607910A2 (el) |
CA (1) | CA2602121C (el) |
CY (1) | CY1111983T1 (el) |
DK (1) | DK1867332T3 (el) |
ES (1) | ES2368078T3 (el) |
NO (1) | NO339713B1 (el) |
NZ (1) | NZ561675A (el) |
PL (1) | PL1867332T3 (el) |
PT (1) | PT1867332E (el) |
RU (1) | RU2396955C2 (el) |
SI (1) | SI1867332T1 (el) |
WO (1) | WO2006109642A1 (el) |
ZA (1) | ZA200708530B (el) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006264649A1 (en) * | 2005-06-30 | 2007-01-11 | Prosidion Limited | GPCR agonists |
ZA200805604B (en) | 2005-12-29 | 2009-12-30 | Toyama Chemical Co Ltd | Novel arylamidine derivative, salt thereof and antifungal agent containing those |
ES2376130T3 (es) | 2006-10-06 | 2012-03-09 | Toyama Chemical Co., Ltd. | Composición farmacéutica que contiene un derivado de fenilamidina y método de utilización de la composición farmacéutica en combinación con un agente antifúngico. |
US20130197036A1 (en) * | 2010-09-30 | 2013-08-01 | Toyama Chemical Co., Ltd. | Transdermal absorption preparation |
EA032840B8 (ru) | 2011-06-22 | 2020-06-18 | Вайоми Терапеутикс Лимитед | Пролекарства на основе конъюгатов противогрибковых агентов и их применение |
MX2015016675A (es) | 2013-06-04 | 2016-07-15 | Vyome Biosciences Pvt Ltd | Particulas recubiertas y composiciones que comprenden las mismas. |
KR101658365B1 (ko) | 2015-06-10 | 2016-09-22 | 주식회사 케어사이드 | 피부 감염의 예방 및 치료용 조성물 |
EP3484447A4 (en) * | 2016-07-12 | 2020-07-22 | Matinas BioPharma Nanotechnologies, Inc. | DECOCHLATED ANTIMYCOTIC COMPOUNDS FOR ADMINISTRATION IN THE CENTRAL NERVOUS SYSTEM AND FOR TREATING CRYPTOCOCCUS |
WO2019118527A1 (en) * | 2017-12-14 | 2019-06-20 | The Johns Hopkins University | Novel anti-fungal inhibitors |
CN110269939A (zh) * | 2019-03-12 | 2019-09-24 | 武汉愔紫生物科技有限公司 | 一种治疗真菌分泌蛋白介导的炎症疾病标志物的药物、药物组合物、用途及其使用方法 |
CN114126609B (zh) * | 2019-07-11 | 2024-01-02 | 株式会社赛轮制药 | 原藻病的新型治疗剂 |
BR112022024697A2 (pt) * | 2020-06-03 | 2023-03-07 | Ishihara Sangyo Kaisha | Agente antimicrobiano para animal não humano |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2939292A1 (de) | 1979-09-28 | 1981-04-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | N-phenoxyalkylpiperidin-derivate, verfahrenn zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
JP2865722B2 (ja) | 1989-08-14 | 1999-03-08 | 日産自動車株式会社 | カチオン電着塗料組成物 |
JPH03288051A (ja) | 1990-03-30 | 1991-12-18 | Mazda Motor Corp | カムシャフトおよびその製造方法 |
GB9509631D0 (en) | 1995-05-12 | 1995-07-05 | Sandoz Ltd | Antifungal combination |
CZ88499A3 (cs) * | 1996-09-12 | 1999-10-13 | Merck And Co., Inc. | Kombinace látek s antifungálním účinkem |
AUPQ066399A0 (en) | 1999-05-31 | 1999-06-24 | Fujisawa Pharmaceutical Co., Ltd. | Antifungal combination use |
WO2003074476A1 (fr) * | 2002-03-06 | 2003-09-12 | Toyama Chemical Co., Ltd. | Nouveau derive d'arylamidine ou sel de celui-ci |
JP4937506B2 (ja) | 2003-09-05 | 2012-05-23 | 富山化学工業株式会社 | 新規なアリールアミジン誘導体またはその塩 |
AU2005258613B2 (en) | 2004-06-30 | 2011-03-17 | Toyama Chemical Co., Ltd. | Novel arylamidine derivative, salt thereof, and antifungal containing these |
-
2006
- 2006-04-05 BR BRPI0607910-5A patent/BRPI0607910A2/pt not_active Application Discontinuation
- 2006-04-05 PT PT06731152T patent/PT1867332E/pt unknown
- 2006-04-05 CA CA2602121A patent/CA2602121C/en active Active
- 2006-04-05 RU RU2007141162/15A patent/RU2396955C2/ru active
- 2006-04-05 AU AU2006234228A patent/AU2006234228B2/en active Active
- 2006-04-05 DK DK06731152.2T patent/DK1867332T3/da active
- 2006-04-05 CN CN2006800106796A patent/CN101151032B/zh active Active
- 2006-04-05 NZ NZ561675A patent/NZ561675A/en unknown
- 2006-04-05 PL PL06731152T patent/PL1867332T3/pl unknown
- 2006-04-05 ES ES06731152T patent/ES2368078T3/es active Active
- 2006-04-05 US US11/910,999 patent/US8993603B2/en active Active
- 2006-04-05 KR KR1020077024236A patent/KR101325620B1/ko active IP Right Grant
- 2006-04-05 SI SI200631142T patent/SI1867332T1/sl unknown
- 2006-04-05 JP JP2007512933A patent/JP5216323B2/ja active Active
- 2006-04-05 ZA ZA200708530A patent/ZA200708530B/xx unknown
- 2006-04-05 WO PCT/JP2006/307204 patent/WO2006109642A1/ja active Application Filing
- 2006-04-05 EP EP06731152A patent/EP1867332B1/en active Active
-
2007
- 2007-09-17 NO NO20074723A patent/NO339713B1/no unknown
-
2011
- 2011-08-30 CY CY20111100835T patent/CY1111983T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO20074723L (no) | 2007-12-28 |
PT1867332E (pt) | 2011-11-03 |
CA2602121A1 (en) | 2006-10-19 |
RU2396955C2 (ru) | 2010-08-20 |
CN101151032B (zh) | 2011-06-22 |
DK1867332T3 (da) | 2011-09-19 |
NZ561675A (en) | 2010-07-30 |
RU2007141162A (ru) | 2009-05-20 |
EP1867332A1 (en) | 2007-12-19 |
EP1867332A4 (en) | 2010-01-27 |
US8993603B2 (en) | 2015-03-31 |
US20090087480A1 (en) | 2009-04-02 |
WO2006109642A1 (ja) | 2006-10-19 |
BRPI0607910A2 (pt) | 2010-03-23 |
KR101325620B1 (ko) | 2013-11-06 |
SI1867332T1 (sl) | 2011-11-30 |
KR20080002854A (ko) | 2008-01-04 |
NO339713B1 (no) | 2017-01-23 |
CN101151032A (zh) | 2008-03-26 |
AU2006234228A1 (en) | 2006-10-19 |
EP1867332B1 (en) | 2011-08-24 |
CA2602121C (en) | 2014-09-23 |
PL1867332T3 (pl) | 2012-01-31 |
ZA200708530B (en) | 2009-04-29 |
ES2368078T3 (es) | 2011-11-14 |
JPWO2006109642A1 (ja) | 2008-11-13 |
JP5216323B2 (ja) | 2013-06-19 |
AU2006234228B2 (en) | 2011-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1111983T1 (el) | Φαρμακευτικη συνθεση και μεθοδος χρησης αντιμυκητιακου παραγοντα σε συνδυασμο | |
CY2017040I2 (el) | Συνθεσεις και μεθοδοι για διαμορφωση ματισματος smn2 | |
CY2017027I2 (el) | Σταθεροποιημενες συνθεσεις πτητικων αλκυλιωτικων παραγοντων και μεθοδοι χρησης αυτων | |
CY1112225T1 (el) | Ενωσεις κυκλικης αμινης και παραγων ελεγχου ζιζανιων | |
CY1110026T1 (el) | Ενωσεις πιπεραζινης βενζισοξαζολης και μεθοδοι χρησης εξ αυτων | |
CY1112886T1 (el) | Ανοσοκατασταλτικος παραγοντας ο οποιος περιλαμβανει μια ετεροκυκλικη ενωση ως δραστικο συστατικο | |
CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
CY1110392T1 (el) | Υποκατεστημενα παραγωγα μορφολινης και θειομορφολινης | |
ECSP077335A (es) | Inhibidores de la interaccion entre mdm2 y p53 | |
ECSP088246A (es) | Nuevos derivados de benzotiazolona | |
CY2019042I1 (el) | Οφθαλμολογικες συνθεσεις και η χρηση τους | |
CY1110137T1 (el) | Συμπυκνωμενες τρικυκλικες ενωσεις peri χρησιμες ως αντιβακτηριακοι παραγοντες | |
CY1109010T1 (el) | γ-ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ | |
CY1110221T1 (el) | Σταθερα φαρμακευτικα σκευασματα νατριουχου μοντελουκαστης | |
ATE548374T1 (de) | 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren | |
CY1114574T1 (el) | Παραγωγα πιπεριδινης και πιπεραζινης για τη θεραπεια ογκων | |
CR8766A (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso | |
ATE426599T1 (de) | Thiazolylpiperidin derivate als mtp inhibitoren | |
PA8667201A1 (es) | Nuevos compuestos farmaceuticos | |
CY1106679T1 (el) | Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα | |
ECSP045245A (es) | N-aril-2-oxazolidinona-5-carboxamidas y sus derivados | |
UY31145A1 (es) | Derivado de 17b+ciano-18a-homo-19-nor-androst-4-eno, su uso y medicamento que lo contiene | |
AR059445A1 (es) | Composiciones de antimicoticos ramnolipidicos y metodos de uso relacionados | |
ATE496049T1 (de) | Als monoamin wiederaufnahmehemmer geeignete 8- azabicycloä3.2.1üoctanderivate | |
EA200602017A1 (ru) | КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ |